Marsi Bionics aims to invest the capital raised in the round in financing the company's international expansion, accessing new markets, and in the industrialization of production...
In 2021, the company achieved a CE marking from the European Union for the world's first exoskeleton to help pediatric patients with spinal muscular atrophy (SMA) walk. The...